MY102901A - Synthetic vaccines for foot and mouth disease. - Google Patents

Synthetic vaccines for foot and mouth disease.

Info

Publication number
MY102901A
MY102901A MYPI87001857A MYPI19871857A MY102901A MY 102901 A MY102901 A MY 102901A MY PI87001857 A MYPI87001857 A MY PI87001857A MY PI19871857 A MYPI19871857 A MY PI19871857A MY 102901 A MY102901 A MY 102901A
Authority
MY
Malaysia
Prior art keywords
cys
sequence
amino acid
foot
mouth disease
Prior art date
Application number
MYPI87001857A
Other languages
English (en)
Inventor
Dennis Dimarchi Richard
Stephen Brooke Gerald
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP86303978A external-priority patent/EP0204480B1/fr
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY102901A publication Critical patent/MY102901A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C13/00Fibre or filament compositions
    • C03C13/04Fibre optics, e.g. core and clad fibre compositions
    • C03C13/045Silica-containing oxide glass compositions
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03BMANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B37/00Manufacture or treatment of flakes, fibres, or filaments from softened glass, minerals, or slags
    • C03B37/01Manufacture of glass fibres or filaments
    • C03B37/012Manufacture of preforms for drawing fibres or filaments
    • C03B37/014Manufacture of preforms for drawing fibres or filaments made entirely or partially by chemical means, e.g. vapour phase deposition of bulk porous glass either by outside vapour deposition [OVD], or by outside vapour phase oxidation [OVPO] or by vapour axial deposition [VAD]
    • C03B37/018Manufacture of preforms for drawing fibres or filaments made entirely or partially by chemical means, e.g. vapour phase deposition of bulk porous glass either by outside vapour deposition [OVD], or by outside vapour phase oxidation [OVPO] or by vapour axial deposition [VAD] by glass deposition on a glass substrate, e.g. by inside-, modified-, plasma-, or plasma modified- chemical vapour deposition [ICVD, MCVD, PCVD, PMCVD], i.e. by thin layer coating on the inside or outside of a glass tube or on a glass rod
    • C03B37/01807Reactant delivery systems, e.g. reactant deposition burners
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03BMANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2201/00Type of glass produced
    • C03B2201/06Doped silica-based glasses
    • C03B2201/30Doped silica-based glasses doped with metals, e.g. Ga, Sn, Sb, Pb or Bi
    • C03B2201/34Doped silica-based glasses doped with metals, e.g. Ga, Sn, Sb, Pb or Bi doped with rare earth metals, i.e. with Sc, Y or lanthanides, e.g. for laser-amplifiers
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03BMANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00Glass deposition burners
    • C03B2207/80Feeding the burner or the burner-heated deposition site
    • C03B2207/81Constructional details of the feed line, e.g. heating, insulation, material, manifolds, filters
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03BMANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00Glass deposition burners
    • C03B2207/80Feeding the burner or the burner-heated deposition site
    • C03B2207/85Feeding the burner or the burner-heated deposition site with vapour generated from liquid glass precursors, e.g. directly by heating the liquid
    • C03B2207/87Controlling the temperature
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03BMANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2207/00Glass deposition burners
    • C03B2207/80Feeding the burner or the burner-heated deposition site
    • C03B2207/90Feeding the burner or the burner-heated deposition site with vapour generated from solid glass precursors, i.e. by sublimation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Glass Melting And Manufacturing (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MYPI87001857A 1985-06-03 1987-09-22 Synthetic vaccines for foot and mouth disease. MY102901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74068085A 1985-06-03 1985-06-03
EP86303978A EP0204480B1 (fr) 1985-06-03 1986-05-27 Vaccins synthétiques pour la fièvre aphteuse

Publications (1)

Publication Number Publication Date
MY102901A true MY102901A (en) 1993-03-31

Family

ID=24977581

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001857A MY102901A (en) 1985-06-03 1987-09-22 Synthetic vaccines for foot and mouth disease.

Country Status (4)

Country Link
EP (1) EP0223853A1 (fr)
JP (1) JPS62502748A (fr)
MY (1) MY102901A (fr)
WO (1) WO1986007348A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645524A (en) * 1985-04-22 1987-02-24 Corning Glass Works Method for making sodium-containing glass
US4936650A (en) * 1986-04-24 1990-06-26 British Telecommunications Public Limited Company Optical wave guides
GB8713698D0 (en) * 1987-06-11 1987-07-15 British Telecomm Glass compositions
CA1294802C (fr) * 1986-06-04 1992-01-28 Benjamin J. Ainslie Guides de lumiere et fabrication de ces guides
US4826288A (en) * 1987-04-09 1989-05-02 Polaroid Corporation, Patent Department Method for fabricating optical fibers having cores with high rare earth content
GB8724736D0 (en) * 1987-10-22 1987-11-25 British Telecomm Optical fibre
US5071460A (en) * 1988-03-04 1991-12-10 Nippon Telegraph And Telephone Corporation Process for the preparation of fluoride glass and process for the preparation of optical fiber preform using the fluoride glass
US5145508A (en) * 1988-03-04 1992-09-08 Nippon Telegraph And Telephone Corporation Method of making fluoride glass using barium β-diketones
US5236481A (en) * 1992-02-21 1993-08-17 Corning Incorporated Method of doping porous glass preforms
KR100342189B1 (ko) * 1995-07-12 2002-11-30 삼성전자 주식회사 휘발성복합체를사용한희토류원소첨가광섬유제조방법
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US6192713B1 (en) 1998-06-30 2001-02-27 Sdl, Inc. Apparatus for the manufacture of glass preforms
CA2336339A1 (fr) * 1998-06-30 2000-01-06 Brian M. Laliberte Procede et dispositif de production d'une preforme de fibre optique dopee avec une terre rare
FI116469B (fi) * 1998-10-05 2005-11-30 Liekki Oy Liekkiruiskutusmenetelmä ja -laitteisto monikomponenttilasin valmistamiseksi
EP3950610A1 (fr) * 2020-08-06 2022-02-09 Heraeus Quarzglas GmbH & Co. KG Agent de fluoration alternatif ii : fluosil et formation de suie
EP3950611A1 (fr) * 2020-08-06 2022-02-09 Heraeus Quarzglas GmbH & Co. KG Agent de fluoration alternatif destiné à la fabrication de verre à quartz fluoré
CN115933081B (zh) * 2022-11-18 2023-07-25 宏安集团有限公司 一种半干式光纤带光缆

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501602A (en) * 1982-09-15 1985-02-26 Corning Glass Works Process for making sintered glasses and ceramics

Also Published As

Publication number Publication date
WO1986007348A1 (fr) 1986-12-18
JPS62502748A (ja) 1987-10-22
EP0223853A1 (fr) 1987-06-03

Similar Documents

Publication Publication Date Title
ES8707739A1 (es) Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd
MY102901A (en) Synthetic vaccines for foot and mouth disease.
NO904712D0 (no) Nanbh diagnostiske midler og vaksiner.
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
DE3066654D1 (en) Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use
DK0519547T3 (da) Fjerkrævaccine mod coccidiosis
HK148296A (en) Vaccine for use in the therapeutic treatment of hsv
KR870007201A (ko) 헵타노일- glu-asp-ala-아미노산 면역 자극물질
IL100386A0 (en) Cell free marek's disease virus vaccine
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
DE3361628D1 (en) Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds
LV10626B (en) Peptides
HU904054D0 (en) Medical preparations with stomach protecting effect containing n-benzyl-n-/(1s, 5s)-6,6-dimethyl-bicyclo/3.1.1/hept-2-yl-etoxy-ethyl/-morpholinium salts
Purcell et al. Approaches to the development of hepatitis-A vaccines: The old and the new.
ATE74770T1 (de) Tc-99m-w-alkylphosphinico-1-hydroxyalkan-1,1diphosphonate enthaltende praeparate zur knochenszintigraphie sowie verfahren zur herstellung dieser praeparate.
SE9003040L (sv) Analoger av cyklolinopeptid a och anvaendning daerav
DE3485972D1 (de) Antigen aktive aminosaeuresequenzen.
TH7280EX (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B
SE8603050D0 (sv) Reagenssats och dess anvendnilng for att bilda (hpasp - anti-hpasp)-immunkomplex, samt diagnostiskt forfarande vid vilet hpasp detekteras
KANCLIR et al. PHASE EQUILIBRIA IN THE MGO-CAO-R 2 O 3-SIO 2 SYSTEM
TH7280A (th) เพปไทด์ที่เป็นแอนติเจนของไวรัสโรคตับอักเสบชนิดnon-A,non-B